论文部分内容阅读
目的:探讨特布他林、普米克令舒联合甲强龙辅助治疗小儿毛细支气管炎的临床疗效。方法:选取我院儿科收治的200例小儿毛细支气管炎患儿,按照随机数表法将其分为两组,观察组与对照组,各100例,对照组给予常规的抗感染、吸氧、止咳、补液、化痰等对症治疗,观察组在此基础上给予特布他林、普米克令舒联合甲强龙辅助治疗,对比两组患儿的临床疗效。结果:两组患儿的治疗总有效率分别为96.00%、80.00%,组间临床疗效比较,观察组明显优于对照组,差异具有统计学意义,P<0.05。结论:特布他林、普米克令舒联合甲强龙辅助治疗小儿毛细支气管炎具有确切的疗效,能显著改善患儿的临床症状和生命体征,促进患儿恢复,且治疗依从性高,值得临床推广应用。
Objective: To investigate the clinical efficacy of terbutaline and pulmicortin combined with methylprednisolone in the treatment of pediatric bronchiolitis. Methods: A total of 200 pediatric patients with bronchiolitis admitted to our hospital were selected and divided into two groups according to the random number table. The observation group and the control group were given 100 cases each. The control group was given routine anti-infective, Cough, rehydration, phlegm and other symptomatic treatment on the basis of the observation group was given terbutaline, Pulmicort respules and methylprednisolone adjuvant therapy, compared the clinical efficacy of two groups of children. Results: The total effective rates of two groups of children were 96.00% and 80.00%, respectively. The clinical curative effect in the two groups was better than that in the control group, the difference was statistically significant (P <0.05). Conclusion: Terbutaline and Pramipexole combined with methylprednisolone adjuvant treatment of children with bronchiolitis has the exact effect, can significantly improve children’s clinical symptoms and vital signs, and promote the recovery of children, and the treatment of compliance, it is worth Clinical application.